logo

AUPH

Aurinia·NASDAQ
--
--(--)
--
--(--)
4.69 / 10
Netural

Fundamental health scores 4.7/10, deemed modest. Strong points include inventory turnover (0.77) and low cost‑of‑sales ratio (11.5%). Liabilities ratio (55%) and interest coverage (35) are acceptable. Revenue growth (~20%) is solid, but overall metrics remain average.

Fundamental(4.69)SentimentTechnical

Analysis Checks(10/10)

Revenue-MV
Value-1.28
Score3/3
Weight29.66%
1M Return8.11%
Total operating revenue (YoY growth rate %)
Value20.38
Score2/3
Weight0.41%
1M Return0.13%
Inventory turnover ratio
Value0.77
Score3/3
Weight-2.91%
1M Return-0.93%
Current liabilities / Total liabilities (%)
Value55.05
Score2/3
Weight1.15%
1M Return0.36%
PB-ROE
Value1.85
Score2/3
Weight27.66%
1M Return7.29%
Long-term debt to working capital ratio (%)
Value0.19
Score3/3
Weight2.59%
1M Return0.87%
Interest coverage ratio (EBIT / Interest expense) (%)
Value35.11
Score2/3
Weight-3.44%
1M Return-1.17%
Operating revenue (YoY growth rate %)
Value20.38
Score2/3
Weight0.16%
1M Return0.05%
Cost of sales ratio (%)
Value11.54
Score3/3
Weight0.86%
1M Return0.26%
Asset-MV
Value-0.55
Score2/3
Weight43.86%
1M Return11.12%
Is AUPH undervalued or overvalued?
  • AUPH scores 4.69/10 on fundamentals and holds a Fair valuation at present. Backed by its 59.91% ROE, 101.47% net margin, 6.61 P/E ratio, 3.26 P/B ratio, and 5250.00% earnings growth, these metrics solidify its Netural investment rating.